item management s discussion and analysis of financial condition and results of operations the selected financial data in item and the consolidated financial statements included in this form k set forth certain data with respect to the financial position  results of operations and cash flows of vencor which should be read in conjunction with the following discussion and analysis 
background information the hillhaven merger was consummated on september  at the time of the hillhaven merger  hillhaven operated nursing centers  retail and institutional pharmacies and assisted and independent living communities with  units 
annualized revenues approximated billion 
see note of the notes to consolidated financial statements for a description of the hillhaven merger 
prior to its merger with vencor  hillhaven completed a merger with nationwide care  inc nationwide the nationwide merger on june  at the time of the nationwide merger  nationwide operated nursing centers containing  licensed beds and four assisted and independent living communities with units 
annualized revenues approximated million 
see note of the notes to consolidated financial statements for a description of the nationwide merger 
as discussed in the notes to consolidated financial statements  the hillhaven merger and nationwide merger have been accounted for by the pooling of interests method 
accordingly  the accompanying consolidated financial statements and financial and operating data included herein give retroactive effect to these transactions and include the combined operations of vencor  hillhaven and nationwide for all periods presented 
in the third quarter of  vencor completed the ipo of atria 
at december   vencor owned  shares  or  of atria s outstanding common stock 
for accounting purposes  the accounts of atria continue to be consolidated with those of vencor and the company has recorded minority interests in the earnings and equity of atria since consummation of the ipo 
see note of the notes to consolidated financial statements for a description of the ipo 
results of operations a summary of revenues follows dollars in thousands prior period revenues have been reclassified to conform with the presentation amount change amount change amount hospitals    nursing centers    non recurring transactions  vencare    atria    elimination   hospital revenues increased in both and from the acquisition of facilities and growth in same store patient days 
hospital patient days rose to  in and to  in price increases in both years were not significant 
excluding the effect of non recurring transactions  nursing center revenue increases resulted primarily from growth in the volume of medicare patients  who typically require higher levels of medical care 
medicare patient days grew to  in and to  in nursing center revenue growth was adversely impacted by a decline in private pay patient days to  in from  in and  in in an effort to attract increased volumes of medicare and private pay patients  the company has adopted a plan to expend approximately million over the next two years to improve existing facilities and expand the range of services provided to accomodate higher acuity patients 
vencare  the company s ancillary services division organized in  provides primarily respiratory and rehabilitation therapy and pharmacy management services to nursing centers and other healthcare providers 
growth in ancillary services revenues in both and was primarily attributable to the expansion of the vencare contract services business 
the number of vencare contracts most of which relate to respiratory therapy grew from at the end of to  and  at december  and  respectively 
revenues from vencor s assisted and independent living business  atria  increased in both years as a result of price increases  growth in occupancy  expansion of ancillary services and  in  the purchase of controlling interest in two communities previously accounted for under the equity method and the effect of two newly constructed communities 
in the fourth quarter of  vencor recorded pretax charges aggregating million million net of tax primarily to complete the integration of hillhaven 
in november  vencor executed a definitive agreement to sell underperforming or non strategic nursing centers in early a charge of million was recorded in connection with the disposition 
in addition  vencor s previously independent institutional pharmacy business  acquired as part of the hillhaven merger  was integrated into vencare  resulting in a charge of million related primarily to costs associated with employee severance and benefit costs approximately employees  facility close down expenses and the writeoff of certain deferred costs for services to be discontinued 
a provision for loss totaling million related to the planned replacement of one hospital and three nursing centers was also recorded in the fourth quarter 
in the third quarter of  vencor recorded pretax charges aggregating million million net of tax primarily in connection with the consummation of the hillhaven merger 
the charges included i million of investment advisory and professional fees  ii million of employee benefit plan and severance costs approximately employees  iii million of losses associated with the planned disposition of certain nursing center properties and iv million of charges to reflect vencor s change in estimates of accrued revenues recorded in connection with certain prior year nursing center third party reimbursement issues 
during  activities related to the elimination of duplicative corporate and operational functions was substantially completed  and management expects that the dispositions of certain nursing center properties will be concluded in operating results for also include pretax charges of million million net of tax recorded in the second quarter related primarily to the nationwide merger 
non recurring transactions related primarily to sales of assets and nursing center restructuring activities increased pretax income by million million net of tax in income from operations for totaled million  compared to million and million for and  respectively 
excluding the effect of non recurring transactions  income from operations increased to million per share fully diluted and to million per share fully diluted in the growth in both periods resulted primarily from increased hospital volumes and growth in higher margin ancillary services in both vencare and the nursing center business and  in  realization of substantial synergies resulting from the hillhaven merger 
management believes that additional revenues resulting from patient cross referrals within the healthcare network created by the hillhaven merger aggregated approximately million in in addition  cost reductions from elimination of duplicative functions  increased cost efficiencies and refinancing of long term debt increased pretax income by approximately million 
for more information concerning the provision for income taxes as well as information regarding differences between effective income tax rates and statutory rates  see note of the notes to consolidated financial statements 
liquidity cash provided by operations totaled million for compared to million for and million for cash payments in and related to non recurring transactions reduced cash flows from operations by approximately million and million  respectively 
during each of the past three years  cash flows from operations have been adversely impacted by growth in the outstanding days of revenues in accounts receivable 
growth in accounts receivable has been primarily related to the integration of acquired hospital facilities  delays in payments from certain state medicaid programs and managed care plans and  in  the restructuring of vencor s pharmacy operations 
management believes that these factors may have an adverse effect on cash flows from operations in concurrent with the consummation of the hillhaven merger  vencor established a billion bank credit facility the vencor billion credit facility to finance the redemption of hillhaven preferred stock  repay certain hillhaven higher rate debt and borrowings under prior revolving credit agreements  and provide sufficient credit for future expansion 
at december   available borrowings under the vencor billion credit facility approximated million 
following completion of the ipo  atria consummated the atria credit facility million to finance its expansion and development program 
at december   amounts available under the atria credit facility aggregated million 
in connection with the theratx merger  vencor consummated a new bank credit facility on march  aggregating billion the vencor billion credit facility  replacing the vencor billion credit facility 
working capital totaled million at december  compared to million at december  cash and cash equivalents at december  includes million related to atria  a substantial portion of which will be used to finance atria s development and expansion program 
management believes that cash flows from operations and amounts available under the vencor billion credit facility are sufficient to meet future expected liquidity needs 
capital resources excluding acquisitions  capital expenditures totaled million for compared to million for and million for planned capital expenditures in excluding acquisitions are expected to approximate million to million and include significant expenditures related to nursing center improvements and the expansion of atria s assisted and independent living business 
management believes that its capital expenditure program is adequate to expand  improve and equip existing facilities 
vencor also expended million  million and million for acquisitions of new facilities and related healthcare businesses and previously leased nursing centers during  and  respectively  of which million  million and million related to additional hospital facilities 
management intends to acquire additional hospitals  nursing centers and ancillary service businesses in the future 
capital expenditures during the last three years were financed primarily through internally generated funds and  in  from the collection of notes receivable aggregating million 
in addition  capital expenditures in were financed through the public offering of million shares of common stock  the proceeds from which totaled million 
vencor intends to finance a substantial portion of its capital expenditures with internally generated funds  additional long term debt and  with respect to atria  proceeds from the ipo 
sources of capital include available borrowings under the vencor billion credit facility  the atria credit facility  public or private debt and equity 
during  vencor repurchased  shares of common stock at an aggregate cost of million 
as discussed in note of the notes to consolidated financial statements  vencor called for redemption all of its outstanding convertible debt securities in the fourth quarter of  resulting in the issuance of approximately  shares of common stock 
approximately million of the convertible securities were redeemed in exchange for cash equal to of face value plus accrued interest 
these transactions had no material effect on earnings per common and common equivalent share 
as discussed in note of the notes to consolidated financial statements  vencor entered into certain interest rate swap agreements in the fourth quarter of to eliminate the impact of changes in interest rates on million of floating rate debt outstanding 
the agreements expire in april million  october million and april million and provide for fixed rates at plus to 
health care legislation congress is currently considering various proposals which could reduce expenditures under certain government health and welfare programs  including medicare and medicaid 
management cannot predict whether such proposals will be adopted  or if adopted  what effect  if any  such proposals would have on its business 
medicare revenues as a percentage of total revenues were  and for  and  respectively  while medicaid percentages of revenues approximated  and for the respective periods 
other information various lawsuits and claims arising in the ordinary course of business are pending against vencor 
resolution of litigation and other loss contingencies is not expected to have a material adverse effect on vencor s liquidity  financial position or results of operations 
the vencor billion credit facility and the atria credit facility contain customary covenants which require maintenance of certain financial ratios and limit amounts of additional debt and repurchases of common stock 
vencor was in compliance with all such covenants at december  during  vencor adopted financial accounting standards board statements no 
 accounting for the impairment of long lived assets and for long lived assets to be disposed of and no 
 accounting for stock based compensation 
see notes and of the notes to consolidated financial statements 
on march   the company consummated the theratx merger  which will be accounted for using the purchase method 
the theratx merger was structured as a cash tender offer in which the company paid for each outstanding share of theratx common stock 
following the completion of the tender offer  the company merged its acquisition subsidiary with and into theratx and theratx became a wholly owned subsidiary of the company 
upon consummation of the theratx merger  each share of theratx common stock not purchased through the tender offer was converted into the right to receive in cash 
see note of the notes to consolidated financial statements 

